These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 22890420)
1. Stimulation of the retinoid X receptor facilitates beta-amyloid clearance across the blood-brain barrier. Bachmeier C; Beaulieu-Abdelahad D; Crawford F; Mullan M; Paris D J Mol Neurosci; 2013 Feb; 49(2):270-6. PubMed ID: 22890420 [TBL] [Abstract][Full Text] [Related]
2. Bexarotene Promotes Cholesterol Efflux and Restricts Apical-to-Basolateral Transport of Amyloid-β Peptides in an In Vitro Model of the Human Blood-Brain Barrier. Kuntz M; Candela P; Saint-Pol J; Lamartinière Y; Boucau MC; Sevin E; Fenart L; Gosselet F J Alzheimers Dis; 2015; 48(3):849-62. PubMed ID: 26402114 [TBL] [Abstract][Full Text] [Related]
3. ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models. Cramer PE; Cirrito JR; Wesson DW; Lee CY; Karlo JC; Zinn AE; Casali BT; Restivo JL; Goebel WD; James MJ; Brunden KR; Wilson DA; Landreth GE Science; 2012 Mar; 335(6075):1503-6. PubMed ID: 22323736 [TBL] [Abstract][Full Text] [Related]
4. Amyloid-β pathology and APOE genotype modulate retinoid X receptor agonist activity in vivo. Tai LM; Koster KP; Luo J; Lee SH; Wang YT; Collins NC; Ben Aissa M; Thatcher GRJ; LaDu MJ J Biol Chem; 2014 Oct; 289(44):30538-30555. PubMed ID: 25217640 [TBL] [Abstract][Full Text] [Related]
5. Astaxanthin exerts protective effects similar to bexarotene in Alzheimer's disease by modulating amyloid-beta and cholesterol homeostasis in blood-brain barrier endothelial cells. Fanaee-Danesh E; Gali CC; Tadic J; Zandl-Lang M; Carmen Kober A; Agujetas VR; de Dios C; Tam-Amersdorfer C; Stracke A; Albrecher NM; Manavalan APC; Reiter M; Sun Y; Colell A; Madeo F; Malle E; Panzenboeck U Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2224-2245. PubMed ID: 31055081 [TBL] [Abstract][Full Text] [Related]
6. A multifaceted role for apoE in the clearance of beta-amyloid across the blood-brain barrier. Bachmeier C; Paris D; Beaulieu-Abdelahad D; Mouzon B; Mullan M; Crawford F Neurodegener Dis; 2013; 11(1):13-21. PubMed ID: 22572854 [TBL] [Abstract][Full Text] [Related]
7. ABCA1 is Necessary for Bexarotene-Mediated Clearance of Soluble Amyloid Beta from the Hippocampus of APP/PS1 Mice. Corona AW; Kodoma N; Casali BT; Landreth GE J Neuroimmune Pharmacol; 2016 Mar; 11(1):61-72. PubMed ID: 26175148 [TBL] [Abstract][Full Text] [Related]
8. RNA-sequencing reveals transcriptional up-regulation of Trem2 in response to bexarotene treatment. Lefterov I; Schug J; Mounier A; Nam KN; Fitz NF; Koldamova R Neurobiol Dis; 2015 Oct; 82():132-140. PubMed ID: 26071899 [TBL] [Abstract][Full Text] [Related]
9. Role of the cannabinoid system in the transit of beta-amyloid across the blood-brain barrier. Bachmeier C; Beaulieu-Abdelahad D; Mullan M; Paris D Mol Cell Neurosci; 2013 Sep; 56():255-62. PubMed ID: 23831388 [TBL] [Abstract][Full Text] [Related]
10. Retinoic acid isomers facilitate apolipoprotein E production and lipidation in astrocytes through the retinoid X receptor/retinoic acid receptor pathway. Zhao J; Fu Y; Liu CC; Shinohara M; Nielsen HM; Dong Q; Kanekiyo T; Bu G J Biol Chem; 2014 Apr; 289(16):11282-11292. PubMed ID: 24599963 [TBL] [Abstract][Full Text] [Related]
11. Influence of Matrix Metallopeptidase 9 on Beta-Amyloid Elimination Across the Blood-Brain Barrier. Shackleton B; Ringland C; Abdullah L; Mullan M; Crawford F; Bachmeier C Mol Neurobiol; 2019 Dec; 56(12):8296-8305. PubMed ID: 31209784 [TBL] [Abstract][Full Text] [Related]
12. Possible Molecular Interactions of Bexarotene - A Retinoid Drug and Alzheimer's Aβ Peptide: A Docking Study. Mirza Z; Beg MA Curr Alzheimer Res; 2017; 14(3):327-334. PubMed ID: 27842487 [TBL] [Abstract][Full Text] [Related]
13. Selective dihydropyiridine compounds facilitate the clearance of β-amyloid across the blood-brain barrier. Bachmeier C; Beaulieu-Abdelahad D; Mullan M; Paris D Eur J Pharmacol; 2011 Jun; 659(2-3):124-9. PubMed ID: 21497592 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of ADAM10 promotes the clearance of Aβ across the BBB by reducing LRP1 ectodomain shedding. Shackleton B; Crawford F; Bachmeier C Fluids Barriers CNS; 2016 Aug; 13(1):14. PubMed ID: 27503326 [TBL] [Abstract][Full Text] [Related]
15. Transport pathways for clearance of human Alzheimer's amyloid beta-peptide and apolipoproteins E and J in the mouse central nervous system. Bell RD; Sagare AP; Friedman AE; Bedi GS; Holtzman DM; Deane R; Zlokovic BV J Cereb Blood Flow Metab; 2007 May; 27(5):909-18. PubMed ID: 17077814 [TBL] [Abstract][Full Text] [Related]
16. Reversal of apoE4-driven brain pathology and behavioral deficits by bexarotene. Boehm-Cagan A; Michaelson DM J Neurosci; 2014 May; 34(21):7293-301. PubMed ID: 24849361 [TBL] [Abstract][Full Text] [Related]
18. Oleocanthal enhances amyloid-β clearance from the brains of TgSwDI mice and in vitro across a human blood-brain barrier model. Qosa H; Batarseh YS; Mohyeldin MM; El Sayed KA; Keller JN; Kaddoumi A ACS Chem Neurosci; 2015 Nov; 6(11):1849-59. PubMed ID: 26348065 [TBL] [Abstract][Full Text] [Related]
19. Bexarotene Modulates Retinoid-X-Receptor Expression and Is Protective Against Neurotoxic Endoplasmic Reticulum Stress Response and Apoptotic Pathway Activation. Dheer Y; Chitranshi N; Gupta V; Abbasi M; Mirzaei M; You Y; Chung R; Graham SL; Gupta V Mol Neurobiol; 2018 Dec; 55(12):9043-9056. PubMed ID: 29637440 [TBL] [Abstract][Full Text] [Related]
20. Central role for PICALM in amyloid-β blood-brain barrier transcytosis and clearance. Zhao Z; Sagare AP; Ma Q; Halliday MR; Kong P; Kisler K; Winkler EA; Ramanathan A; Kanekiyo T; Bu G; Owens NC; Rege SV; Si G; Ahuja A; Zhu D; Miller CA; Schneider JA; Maeda M; Maeda T; Sugawara T; Ichida JK; Zlokovic BV Nat Neurosci; 2015 Jul; 18(7):978-87. PubMed ID: 26005850 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]